Tokyo, May 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061551) titled 'Elucidating the Association Between First-Line Antimalarial Drug Susceptibility and Patient Outcomes in African Severe Malaria: A Prospective Cohort Study Towards Improving Survival Rates' on May 15.

Study Type: Observational

Primary Sponsor: Institute - Juntendo University

Condition: Condition - Malaria Classification by malignancy - Others Genomic information - YES

Objective: Narrative objectives1 - Although malaria-related deaths initially declined following the introduction of the highly effective antimalarial drug artemisinin, the trend reversed in 2020 and has since plateaued, resulting in approximately 600,...